Anticoagulant-associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume...

Area of Science:

• Internal Medicine
• Cardiology
• Gastroenterology

Background:

• Gastrointestinal (GI) bleeding is the most common major bleeding complication associated with oral anticoagulants (OACs).
• Patients experiencing major GI bleeding face significant morbidity and up to 10% short-term mortality.
• Uncertainty exists regarding the optimal strategy for resuming OACs after bleeding resolution.

Purpose of the Study:

• To provide a decision-making framework for OAC resumption after GI bleeding.
• To summarize the epidemiology and clinical outcomes of OAC-associated GI bleeding.
• To outline strategies for preventing recurrent GI bleeding.

Main Methods:

• Review of existing literature on OAC-associated GI bleeding.
• Analysis of observational studies on OAC resumption risks (thromboembolism, recurrent bleeding).
• Development of an approach for risk stratification and timing of OAC resumption.

Main Results:

• Limited evidence suggests OAC resumption may lower thromboembolism risk but increase recurrent bleeding risk.
• Absolute risks and optimal timing for OAC resumption remain unclear due to study limitations and confounding.
• Individualized patient assessment, incorporating values and preferences, is crucial.

Conclusions:

• A structured approach is needed to guide OAC resumption after GI bleeding.
• Balancing the risks of recurrent thrombosis against re-bleeding is essential.
• Personalized decision-making, informed by evidence and patient preferences, should guide therapy.